Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Adenosquamous | 1 | 2023 | 66 | 0.840 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2023 | 101 | 0.840 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2022 | 44 | 0.770 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2022 | 135 | 0.720 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 21056 | 0.700 |
Why?
|
| Phyllodes Tumor | 1 | 2020 | 54 | 0.680 |
Why?
|
| Carboxyhemoglobin | 1 | 2020 | 83 | 0.670 |
Why?
|
| Blood Substitutes | 1 | 2020 | 57 | 0.670 |
Why?
|
| Angiolipoma | 1 | 2019 | 12 | 0.660 |
Why?
|
| Mastectomy, Modified Radical | 1 | 2019 | 59 | 0.650 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 97 | 0.620 |
Why?
|
| Benzimidazoles | 1 | 2024 | 864 | 0.610 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 241 | 0.560 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2023 | 790 | 0.540 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 920 | 0.460 |
Why?
|
| Fluorocarbons | 1 | 2020 | 497 | 0.460 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 1188 | 0.450 |
Why?
|
| Hemoglobins | 1 | 2020 | 1530 | 0.440 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1297 | 0.420 |
Why?
|
| Paclitaxel | 1 | 2019 | 1728 | 0.380 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 1050 | 0.370 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 2176 | 0.370 |
Why?
|
| Anemia | 1 | 2020 | 1511 | 0.340 |
Why?
|
| Research Design | 1 | 2024 | 6209 | 0.290 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 6364 | 0.260 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2024 | 34 | 0.230 |
Why?
|
| Breast | 2 | 2023 | 1946 | 0.220 |
Why?
|
| GATA3 Transcription Factor | 1 | 2023 | 163 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5444 | 0.200 |
Why?
|
| Ki-67 Antigen | 1 | 2024 | 629 | 0.190 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 11083 | 0.180 |
Why?
|
| Camptothecin | 1 | 2023 | 600 | 0.170 |
Why?
|
| Aminopyridines | 1 | 2024 | 576 | 0.170 |
Why?
|
| Gene Amplification | 1 | 2023 | 1091 | 0.160 |
Why?
|
| Muscles | 1 | 2023 | 1578 | 0.160 |
Why?
|
| Hyperplasia | 1 | 2021 | 1144 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2024 | 10429 | 0.150 |
Why?
|
| Urinary Bladder | 1 | 2023 | 1154 | 0.140 |
Why?
|
| Ovary | 1 | 2022 | 956 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 1 | 2024 | 1352 | 0.130 |
Why?
|
| Antioxidants | 1 | 2024 | 1670 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1761 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 2024 | 2968 | 0.130 |
Why?
|
| Disinfection | 1 | 2018 | 207 | 0.130 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2019 | 616 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 5389 | 0.120 |
Why?
|
| Pancreas | 1 | 2020 | 1700 | 0.110 |
Why?
|
| Receptor, erbB-2 | 1 | 2023 | 2593 | 0.100 |
Why?
|
| Mammography | 1 | 2021 | 2423 | 0.090 |
Why?
|
| Female | 8 | 2024 | 396112 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 13451 | 0.080 |
Why?
|
| Humans | 12 | 2024 | 765968 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 1393 | 0.080 |
Why?
|
| Cross Infection | 1 | 2018 | 1427 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12768 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11022 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11206 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2018 | 3800 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12976 | 0.060 |
Why?
|
| Inflammation | 1 | 2023 | 10850 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 385 | 0.050 |
Why?
|
| Mutation | 1 | 2024 | 30198 | 0.040 |
Why?
|
| Staphylococcus | 1 | 2018 | 145 | 0.040 |
Why?
|
| Hygiene | 1 | 2018 | 95 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 17075 | 0.040 |
Why?
|
| Disinfectants | 1 | 2018 | 130 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 2023 | 981 | 0.030 |
Why?
|
| Male | 3 | 2023 | 363698 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 2210 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65188 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2024 | 3141 | 0.030 |
Why?
|
| Mice | 3 | 2024 | 81819 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 81514 | 0.030 |
Why?
|
| Cell Movement | 1 | 2024 | 5194 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 3596 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3946 | 0.020 |
Why?
|
| Aged | 2 | 2023 | 171117 | 0.020 |
Why?
|
| Middle Aged | 2 | 2023 | 223009 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 8611 | 0.020 |
Why?
|
| Animals | 3 | 2024 | 168764 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15842 | 0.020 |
Why?
|
| Prognosis | 1 | 2024 | 29922 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20124 | 0.010 |
Why?
|
Concepts
(83)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_